Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The clinical trial record for pembrolizumab combined with BCG in high-risk bladder and upper-tract urothelial cancer is displayed, including study design, eligibility criteria, treatment arms, and outcome measures.
    Difference
    51%
    Check dated 2026-11-11T02:23:12.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The footer’s site revision label changed from v3.7.2 to v3.8.0 while the study page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T01:20:07.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    A general NIH website-transition notice was added above the ClinicalTrials.gov navigation, and the site revision changed from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-21T01:15:01.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The displayed site revision changed from v3.7.0 to v3.7.1 while the page continued to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-07T01:18:21.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error instead of the study record content, with a minimal header and footer. This indicates that access to the study details is blocked and the content is not available for review.
    Difference
    18%
    Check dated 2026-09-23T01:22:04.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The page's revision label updated to Revision: v3.7.0, replacing Revision: v3.6.6; this reflects a page version update without altering the study information.
    Difference
    0.1%
    Check dated 2026-09-16T00:20:59.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.